Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec, Canada.
PLoS One. 2012;7(1):e30139. doi: 10.1371/journal.pone.0030139. Epub 2012 Jan 23.
The identification of the signals that should be provided by antigen-presenting cells (APCs) to induce a CD8(+) T cell response in vivo is essential to improve vaccination strategies using antigen-loaded APCs. Although dendritic cells have been extensively studied, the ability of other APC types, such as B cells, to induce a CD8(+) T cell response have not been thoroughly evaluated.
METHODOLOGY/PRINCIPAL FINDINGS: In this manuscript, we have characterized the ability of CD40-activated B cells, stimulated or not with Toll-like receptor (TLR) agonists (CpG or lipopolysaccharide) to induce the response of mouse naïve CD8(+) T cells in vivo. Our results show that CD40-activated B cells can directly present antigen to naïve CD8(+) T cells to induce the generation of potent effectors able to secrete cytokines, kill target cells and control a Listeria monocytogenes infection. However, CD40-activated B cell immunization did not lead to the proper formation of CD8(+) memory T cells and further maturation of CD40-activated B cells with TLR agonists did not promote the development of CD8(+) memory T cells. Our results also suggest that inefficient generation of CD8(+) memory T cells with CD40-activated B cell immunization is a consequence of reduced Bcl-6 expression by effectors and enhanced contraction of the CD8(+) T cell response.
Understanding why CD40-activated B cell immunization is defective for the generation of memory T cells and gaining new insights about signals that should be provided by APCs are key steps before translating the use of CD40-B cell for therapeutic vaccination.
鉴定抗原呈递细胞(APC)在体内诱导 CD8(+) T 细胞反应所需的信号对于改进使用负载抗原的 APC 的疫苗接种策略至关重要。尽管树突状细胞已被广泛研究,但其他 APC 类型(如 B 细胞)诱导 CD8(+) T 细胞反应的能力尚未得到彻底评估。
方法/主要发现:在本文中,我们描述了 CD40 激活的 B 细胞(无论是否用 Toll 样受体(TLR)激动剂(CpG 或脂多糖)刺激)在体内诱导小鼠幼稚 CD8(+) T 细胞反应的能力。我们的结果表明,CD40 激活的 B 细胞可以直接将抗原呈递给幼稚的 CD8(+) T 细胞,诱导产生能够分泌细胞因子、杀伤靶细胞和控制李斯特菌感染的有效效应物。然而,CD40 激活的 B 细胞免疫接种并未导致形成适当的 CD8(+)记忆 T 细胞,并且用 TLR 激动剂进一步成熟 CD40 激活的 B 细胞也没有促进 CD8(+)记忆 T 细胞的发育。我们的结果还表明,CD40 激活的 B 细胞免疫接种导致 CD8(+)记忆 T 细胞生成效率低下是由于效应物中 Bcl-6 表达减少和 CD8(+) T 细胞反应的收缩增强所致。
了解为什么 CD40 激活的 B 细胞免疫接种对记忆 T 细胞的产生有缺陷,并获得关于 APC 应提供的信号的新见解,是在将 CD40-B 细胞用于治疗性疫苗接种之前进行转化的关键步骤。